New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

Acquired Myasthenia Gravis (MG) is a neuromuscular disease caused by autoantibodies against components of the neuromuscular junction. It is a prototype organ-specific autoimmune disease with well-defined antigenic targets mainly the nicotinic acetylcholine receptor (AChR). Patients suffer from fluct...

Descripción completa

Detalles Bibliográficos
Autores principales: Behin, Anthony, Le Panse, Rozen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087460/
https://www.ncbi.nlm.nih.gov/pubmed/30010142
http://dx.doi.org/10.3233/JND-170294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087460/
https://www.ncbi.nlm.nih.gov/pubmed/30010142
http://dx.doi.org/10.3233/JND-170294

Ejemplares similares